Literature DB >> 4835964

Use of the umbilical vein to study the splanchnic and portal beds in shock and trauma: II. Metabolic studies.

J R Hankins, W Gill, M E Zipser, W Blumenfeld, R A Cowley.   

Abstract

Perumbilical portal vein catheters and arterial and central venous catheters were inserted in 16 patients recovering from trauma or other shock-producing events, and in 5 patients who later developed shock. This permitted serial measurement of blood gases, pH, and the levels of ammonia, lactate and certain other metabolites in all three circulatory systems simultaneously. Nine of the trauma patients were never in shock, had no liver disease or injury and consequently formed a baseline group for comparison with the shock patients. In the shock patients there was a significant degree of hypoxemia in the portal venous blood and an increase in the arterialportal oxygen saturation difference. Their portal venous blood showed a lower pH and a higher pCO(2) than did the portal blood of the patients who had never been in shock. In 3 of the 4 shock patients who died, the total blood lactate showed a greater increase in portal venous than in the arterial or central venous blood. In shock there was also an increase in portal venous blood ammonia which was later accompanied by increments in arterial and central venous blood ammonia. This suggests impairment of hepatic urea synthesis, allowing escape of ammonia through the liver. These phenomena, when added to the finding previously reported of an elevated portal venous pressure in some shock patients, lend support to the hypothesis that in certain cases of shock there is increased impedance to flow of portal blood through the liver with resultant stasis in the portal-splanchnic bed and ischemichypoxic hepatocellular injury.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4835964      PMCID: PMC1343617          DOI: 10.1097/00000658-197407000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  HEPATIC PHYSIOLOGIC AND MORPHOLOGIC ALTERATIONS IN HEMORRHAGIC SHOCK.

Authors:  W C SHOEMAKER; P B SZANTO; L B FITCH; N R BRILL
Journal:  Surg Gynecol Obstet       Date:  1964-04

2.  THE UMBILICAL VEIN IN THE ADULT: DIAGNOSIS, TREATMENT AND RESEARCH.

Authors:  J H BAYLY; O G CARBALHAES
Journal:  Am Surg       Date:  1964-01       Impact factor: 0.688

3.  Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery.

Authors:  N TYGSTRUP; K WINKLER; K MELLEMGAARD; M ANDREASSEN
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

4.  Portography: a preliminary report of a new technique via the umbilical vein.

Authors:  O GONZALEZ CARBALHAES
Journal:  Clin Proc Child Hosp Dist Columbia       Date:  1959-05

5.  The role of the spleen and the hepatic artery in the regulation of liver blood flow.

Authors:  J GRAYSON; D MENDEL
Journal:  J Physiol       Date:  1957-04-03       Impact factor: 5.182

6.  Biochemical and hematologic characteristics of blood from the hepatic portal vein in man.

Authors:  H R BIERMAN; L P WHITE; K H KELLY; H L STEINBACH
Journal:  J Appl Physiol       Date:  1953-04       Impact factor: 3.531

7.  Use of the umbilical vein for manometric and radiographic studies of the splanchnic and portal beds in shock and trauma.

Authors:  J R Hankins; R A Cowley; M E Zipser; S Z Turney
Journal:  Ann Surg       Date:  1972-07       Impact factor: 12.969

8.  Direct portal hepatography and metabolic studies via the reopened umbilical vein. Effect of vasoactive drugs on portal pressure, blood gases and lactates.

Authors:  J J White
Journal:  Am Surg       Date:  1968-12       Impact factor: 0.688

9.  The hemodynamic bisection of the liver.

Authors:  A Kaplan; J I Davies; M Field
Journal:  Surgery       Date:  1969-08       Impact factor: 3.982

10.  [Portal catheterization. Transumbilical porto-manometry and porto-hepatography: physiopathological and clinical remarks].

Authors:  E Storti; E Lusvarghi; M Lenzi; G Gibertini; A Torricelli; E Zambarda; P L Prati; G Fontana; A Rivi; C Montanari
Journal:  Presse Med       Date:  1966-01-26       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.